Documents

Discussions Technicals Forecast Seasonals Options

Foghorn Therapeutics Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Foghorn Therapeutics Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 05, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 14, 2025

Earnings release8-K

Quarterly report10-Q

AACR Annual Meeting 2025

Apr 29, 2025

Slides

2024

Q4 2024

Mar 06, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 04, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 08, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 06, 2024

Quarterly report10-Q

Earnings release8-K

Status Update

Apr 09, 2024

Press release

Slides

2023

Q4 2023

Mar 07, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 02, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 04, 2023

Quarterly report10-Q

Q1 2023

May 08, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 09, 2023

Earnings release8-K

Annual report10-K

Q3 2022

Nov 08, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

Oct 09, 2022

Earnings release8-K

Q2 2022

Aug 09, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 10, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Nov 09, 2021

Quarterly report10-Q

Earnings release8-K

Q2 2021

Aug 10, 2021

Quarterly report10-Q

Earnings release8-K

2020

Q4 2020

Mar 18, 2021

Annual report10-K